1,4,6- androstatrien-3,17-dione

Revision as of 13:46, 4 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Deadend 1,4,6- androstatrien-3,17-dione, also known as ATD is an aromatase inhibitor used to control estrogen synthesis.[1]

1,4,6- androstatrien-3,17-dione is used in over-the-counter bodybuilding supplements such as Rebound XT, Novedex XT and Inhibit-E, and while not banned, may cause positive urinanalysis results leading to disqualification from competitive sports due it's similar properties to banned substances.[2]

References

  1. Adkins-Regan, Elizabeth (2006-07-06). "Sex steroids modulate changes in social and sexual preference during juvenile development in zebra finches". Hormones and Behaviour. Elsevier Inc. 50 (5): 772–778. Retrieved 2007-10-07. Unknown parameter |coauthors= ignored (help)
  2. "DRUG TESTING" (HTML). Organization of Competitive Bodybuilders. Retrieved 2007-10-07.

Further Reading

  1. ^ Covey DF, Hood WF. (1981). "Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity". Endocrinology 108 (4): 1597-9. PMID 7472286.

Template:Pharma-stub

Template:WikiDoc Sources